Of all the communities touched by the COVID-19 pandemic, healthcare professionals (HCPs) are arguably among those most affected. Specialists on the front lines in primary care, critical care, infectious diseases, and pulmonology roles have experienced COVID-19 first hand—often risking their own health and that of their families to help. A new report from Apollo Intelligence provides a barometer on physicians’ sentiments for 2022, and together with other research, frames a wake-up call to medical device and pharma teams in charge of building a brand presence with prescribers.

Join this webinar session for case study examples that demonstrate how innovative pharma marketers are utilizing social networks as a force for good to cultivate lasting consumer relationships and improve patient outcomes. Learn what’s working – and what pitfalls to avoid – in today’s rapidly evolving digital landscape.

Civica Rx announced the organization’s intentions to manufacture and distribute insulins that will be available to individuals with diabetes at lower prices than those presently on the market.

A national survey by Press Ganey – the leader in healthcare consumer and employee experience – revealed heightened consumer expectations and information needs from pharma brands, presenting a unique opportunity for life sciences companies to drive brand strength.

Drew Desjardins, Avalere Health

Historically, therapies focusing on niche markets face tremendous obstacles, from drug development and clinical trials to drug access. Drew Desjardins – EVP, Chief Strategy Officer, Fishawack Health – analyzes several key challenges for brand marketers readying to launch products in these small markets, along with solutions for driving better stakeholder experiences.  

Prices increased on 810 different medications by the end of January 2021, not only on branded medications but also some generic drugs, according to a pricing report from GoodRx Health.

Read Roberts, director of Key Opinion Leaders (KOL) data solutions at PRECISIONscientia, believes 2022 will see social media platforms as the new method for handling pharma medical education and peer-to-peer communications. So pharma must embrace a new type of digital sleuthing to find KOLs and Digital Opinion Leaders (DOLs), but they must do so carefully and think how to mitigate many risks in this highly regulated market, according to Roberts.

After a rejection from GlaxoSmithKline on a proposed £50 billion (about $68 billion) buyout of GSK’s consumer healthcare business, Unilever announced that the global consumer product giant will not increase its bid.

Stephen Hoelper, President, North America at Doceree, analyzes why life sciences brands need to move beyond vanity metrics for point-of-care campaigns.

As global corporations reach deeper into every part of our lives, marketing is evolving into something unrecognizable. According to Michael Farmer, in the Mad Men Era of the 1960s and 70s, your average creative agency was responsible for roughly 350 deliverables a year—whether they were print copy, radio scripts, or billboard headlines. Today? The average number of deliverables per creative per year is over 10,000.